Precision oncology: Detection and treatment of TRK fusion-positive lung cancers

December 06, 2023 00:21:28
Precision oncology: Detection and treatment of TRK fusion-positive lung cancers
COR2ED - Oncology Medical Conversation
Precision oncology: Detection and treatment of TRK fusion-positive lung cancers

Dec 06 2023 | 00:21:28

/

Show Notes

In this medical education podcast, NTRK CONNECT members Assoc. Prof. Caterina Marchiò (University of Turin, Italy) and Prof. Christian Rolfo (Center of Thoracic Oncology Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, New York, USA) provide pathologist and medical oncologist perspectives about the detection and treatment of TRK fusion-positive lung cancers.

They discuss a number of techniques and strategies to identify this rare fusion in lung cancer patients, before going on to summarise the robust efficacy and safety data for both entrectinib and larotrectinib. Prof. Rolfo briefly covers second-generation therapies in clinical development and describes how liquid biopsy is emerging as a new technique not only to identify but also monitor patients. They conclude by stressing the importance of the collaboration and communication between pathologists and oncologists to test for and identify TRK fusion-positive lung cancer patients.

Other Episodes

Episode

December 06, 2023 00:29:25
Episode Cover

Endometrial carcinoma: Systemic therapies. Part 1 - The physicians' perspective

Join world-renowned gynaecological oncology experts Dr Domenica “Ketta” Lorusso and Dr Mansoor Mirza as they explore the changing landscape of systemic treatment in endometrial...

Listen

Episode

December 06, 2023 00:27:20
Episode Cover

Managing thrombosis: Part 2 - Cancer and thrombosis

In this podcast episode, Prof Dimitrios Tsakiris (Haematologist, Basel University, Switzerland) and Dr Lars Asmis (Haematologist, University of Zurich, Switzerland) discuss the association between...

Listen

Episode

January 20, 2025 00:27:12
Episode Cover

Intermediate HCC – The evolving role of IO

Intermediate HCC – The evolving role of IO  In this final episode of the four-part series on hepatocellular carcinoma (HCC), hosted by the Oncology...

Listen